Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes

In the last decade, human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM)-based cell therapy has drawn broad attention as a potential therapy for treating injured hearts. However, mass production of hiPSC-CMs remains challenging, limiting their translational potential in regenerative...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hao, Yang, Yuan, Kiskin, Fedir N., Shen, Mengcheng, Zhang, Joe Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469435/
https://www.ncbi.nlm.nih.gov/pubmed/37649113
http://dx.doi.org/10.1186/s13287-023-03470-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469435/
https://www.ncbi.nlm.nih.gov/pubmed/37649113
http://dx.doi.org/10.1186/s13287-023-03470-w

Ejemplares similares